ICU Medical Return on Tangible Equity 2010-2023 | ICUI
Current and historical return on tangible equity values for ICU Medical (ICUI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ICU Medical Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $-0.03B | $-0.22B | 11.36% |
| 2023-09-30 | $-0.03B | $-0.24B | 9.85% |
| 2023-06-30 | $-0.05B | $-0.28B | 14.86% |
| 2023-03-31 | $-0.05B | $-0.32B | 12.64% |
| 2022-12-31 | $-0.07B | $-0.34B | 18.75% |
| 2022-09-30 | $-0.04B | $-0.38B | -103.40% |
| 2022-06-30 | $0.01B | $-0.42B | 1.27% |
| 2022-03-31 | $0.04B | $-0.44B | 4.51% |
| 2021-12-31 | $0.10B | $1.38B | 7.66% |
| 2021-09-30 | $0.11B | $1.36B | 8.28% |
| 2021-06-30 | $0.10B | $1.34B | 8.05% |
| 2021-03-31 | $0.09B | $1.30B | 7.58% |
| 2020-12-31 | $0.09B | $1.27B | 7.24% |
| 2020-09-30 | $0.08B | $1.22B | 7.03% |
| 2020-06-30 | $0.08B | $1.18B | 7.23% |
| 2020-03-31 | $0.09B | $1.14B | 7.58% |
| 2019-12-31 | $0.10B | $1.14B | 8.78% |
| 2019-09-30 | $0.07B | $1.20B | 6.39% |
| 2019-06-30 | $0.05B | $1.17B | 4.13% |
| 2019-03-31 | $0.06B | $1.14B | 4.91% |
| 2018-12-31 | $0.03B | $1.12B | 2.62% |
| 2018-09-30 | $0.09B | $1.12B | 7.91% |
| 2018-06-30 | $0.09B | $1.11B | 8.16% |
| 2018-03-31 | $0.02B | $1.08B | 1.77% |
| 2017-12-31 | $0.07B | $1.04B | 6.98% |
| 2017-09-30 | $0.03B | $0.98B | 3.27% |
| 2017-06-30 | $0.05B | $0.95B | 6.03% |
| 2017-03-31 | $0.10B | $0.98B | 14.49% |
| 2016-12-31 | $0.06B | $0.63B | 10.64% |
| 2016-09-30 | $0.06B | $0.62B | 10.16% |
| 2016-06-30 | $0.06B | $0.59B | 9.91% |
| 2016-03-31 | $0.05B | $0.57B | 9.62% |
| 2015-12-31 | $0.05B | $0.55B | 8.38% |
| 2015-09-30 | $0.05B | $0.56B | 8.96% |
| 2015-06-30 | $0.04B | $0.53B | 7.32% |
| 2015-03-31 | $0.03B | $0.51B | 5.89% |
| 2014-12-31 | $0.03B | $0.50B | 5.41% |
| 2014-09-30 | $0.03B | $0.48B | 6.81% |
| 2014-06-30 | $0.04B | $0.48B | 8.14% |
| 2014-03-31 | $0.04B | $0.47B | 8.71% |
| 2013-12-31 | $0.04B | $0.46B | 9.56% |
| 2013-09-30 | $0.04B | $0.42B | 9.77% |
| 2013-06-30 | $0.04B | $0.40B | 10.42% |
| 2013-03-31 | $0.04B | $0.39B | 11.42% |
| 2012-12-31 | $0.04B | $0.38B | 11.66% |
| 2012-09-30 | $0.05B | $0.36B | 14.08% |
| 2012-06-30 | $0.04B | $0.34B | 13.88% |
| 2012-03-31 | $0.04B | $0.33B | 14.41% |
| 2011-12-31 | $0.04B | $0.31B | 15.07% |
| 2011-09-30 | $0.04B | $0.29B | 12.56% |
| 2011-06-30 | $0.04B | $0.29B | 13.12% |
| 2011-03-31 | $0.03B | $0.27B | 13.56% |
| 2010-12-31 | $0.03B | $0.26B | 12.54% |
| 2010-09-30 | $0.03B | $0.25B | 11.38% |
| 2010-06-30 | $0.02B | $0.23B | 9.99% |
| 2010-03-31 | $0.02B | $0.23B | 8.93% |
| 2009-12-31 | $0.03B | $0.25B | 9.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.534B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.078B | 23.71 |
| Stryker (SYK) | United States | $127.496B | 30.54 |
| Medtronic (MDT) | Ireland | $114.087B | 16.15 |
| Boston Scientific (BSX) | United States | $109.519B | 34.88 |
| EssilorLuxottica (ESLOY) | France | $102.905B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.259B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.110B | 30.15 |
| Koninklijke Philips (PHG) | Netherlands | $25.984B | 20.13 |
| Terumo (TRUMY) | Japan | $25.953B | 36.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.724B | 15.79 |
| Baxter (BAX) | United States | $17.963B | 12.77 |
| Insulet (PODD) | United States | $13.116B | 58.16 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.406B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.382B | 27.41 |
| BellRing Brands (BRBR) | United States | $7.488B | 35.22 |
| Lantheus Holdings (LNTH) | United States | $5.522B | 13.76 |
| Haemonetics (HAE) | United States | $4.862B | 24.05 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.066B | 12.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 15.36 |
| Envista Holdings (NVST) | United States | $3.185B | 13.14 |
| Neogen (NEOG) | United States | $2.933B | 28.21 |
| QuidelOrtho (QDEL) | United States | $2.868B | 15.92 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.735B | 54.17 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| Agios Pharmaceuticals (AGIO) | United States | $1.950B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.761B | 51.61 |
| Warby Parker (WRBY) | United States | $1.639B | 0.00 |
| InMode (INMD) | Israel | $1.550B | 8.24 |
| Owens & Minor (OMI) | United States | $1.424B | 12.41 |
| AdaptHealth (AHCO) | United States | $1.329B | 9.88 |
| National Vision Holdings (EYE) | United States | $1.240B | 39.45 |
| AtriCure (ATRC) | United States | $1.101B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.913B | 0.00 |
| Evolus (EOLS) | United States | $0.851B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.745B | 15.86 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| Valneva SE (VALN) | France | $0.618B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| PetIQ (PETQ) | United States | $0.588B | 19.20 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.494B | 30.91 |
| Jin Medical (ZJYL) | China | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.464B | 39.58 |
| Aurora Cannabis (ACB) | Canada | $0.403B | 0.00 |
| Cerus (CERS) | United States | $0.364B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.364B | 11.71 |
| Biote (BTMD) | United States | $0.357B | 8.21 |
| Zynex (ZYXI) | United States | $0.346B | 47.30 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.35 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.264B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.49 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.171B | 82.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.134B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 8.28 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.085B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.025B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |